Nominate your peers and colleagues for HFSA Awards through February 27!

Heart Failure Seminar: Focus on Ischemic and Valvular Heart Disease

February 2, 2023 - February 2, 2023 | Virtual

Heart Failure Seminar: Focus on Ischemic and Valvular Heart Disease

Debates on Best Outcomes with Percutaneous vs Surgical Interventions

This virtual seminar will feature heart failure experts going head-to-head on percutaneous and surgical interventions in a series of debates. The debate topics? PCI vs CABG, Mitral Clip TEER vs Surgical MVR, and TAVR vs Surgical AVR. You won't want to miss this! View the faculty list to see which experts will be going head-to-head!

HFSA HF Seminars Ischemic and Valvular logo

February 2, 2023
3:00 PM - 4:30 PM ET | Virtual Livestream

Despite the advances in medical therapy, with growing benefit from the “4 pillars” of guideline directed medical therapy (GDMT), subsets of patients derive signification improvement in outcomes utilizing advanced percutaneous and surgical interventions via improvement in coronary flow, valvular function, and pump function.

Intended Audience

This program is intended for physicians, nurses, nurse practitioners, physician assistants, and advanced practice professionals that provide care to patients with heart failure.

The Heart Failure Society of America acknowledges the following for providing an unrestricted educational grant to support the Heart Failure Seminar: Focus on Ischemic and Valvular Heart Disease: Abbott, Medtronic